HKSH, HKUMed and HK Hereditary Breast Cancer Family Registry Collaborate to Advance Research on Gene Mutation of Hereditary Breast and Ovarian Cancers in Hong Kong

(15 November 2023, Hong Kong) HKSH Medical Group (HKSH), LKS Faculty of Medicine of the University of Hong Kong (HKUMed), and the Hong Kong Hereditary Breast Cancer Family Registry (Registry) today announced significant findings from their collaborative research studies on the germline mutation landscape of nearly 4,900 individuals with hereditary breast and/or ovarian cancers in Hong Kong. This pioneering collaboration, ongoing since 2007, aims to facilitate early detection of and targeted treatment strategies on breast and ovarian cancers among high-risk groups and their families.

Please click here for more information.

慎防詐騙提示：近日接獲有公眾人士指稱收到冒充養和醫院的電話，並通知有醫療文件未領取，此類通訊均為冒充來電，切勿回覆或提供個人資料。公眾人士請慎防冒充養和醫療集團或其成員包括養和醫院、養和醫健、養和東區醫療中心、養和癌症中心以及各關聯公司名義的通訊 (虛假網站、電郵或語音來電等)。如有懷疑，切勿提供個人資料，並致電2572 0211與本集團聯絡。

山村園地

桌面版

語言

最新消息

HKSH, HKUMed and HK Hereditary Breast Cancer Family Registry Collaborate to Advance Research on Gene Mutation of Hereditary Breast and Ovarian Cancers in Hong Kong

語言

搜尋表單

最新消息

HKSH, HKUMed and HK Hereditary Breast Cancer Family Registry Collaborate to Advance Research on Gene Mutation of Hereditary Breast and Ovarian Cancers in Hong Kong